Bonaventura, Anthony, O'Connell, Rachel L., Martyn, Julie, DeFazio, Anna, Scurry, James, Friedlander, Michael L., Mapagu, Cristina, Beale, Philip J., McNally, Orla M., Mileshkin, Linda R., Grant, Peter T., Hadley, Alison M., Goh, Jeffery C. H., Sjoquist, Katrin M.. Lippincott Williams & Wilkins; 2017. Paragon (ANZGOG-0903): phase 2 study of Anastrozole in women with estrogen or progesterone receptor-positive platinum-resistant or -refractory recurrent ovarian cancer.